HBW
TECH icon

Hazlett, Burt & Watson’s Bio-Techne TECH Stock Holding History

Hazlett, Burt & Watson’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11K Hold
215
– – ﹤0.01% 686
2025
Q4 		$13K Hold
215
– – ﹤0.01% 667
2025
Q3 		$12K Sell
215
-120
-36% -$6.43K ﹤0.01% 640
2025
Q2 		$17K Buy
335
+100
+43% +$5.03K 0.01% 526
2025
Q1 		$14K Buy
+235
New +$15.9K 0.01% 538

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hazlett, Burt & Watson's TECH Position: Q1 2026 in Review

Hazlett, Burt & Watson held its Bio-Techne (TECH) position steady in Q1 2026 at 215 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #686.

Hazlett, Burt & Watson first reported a position in TECH in Q1 2025 and has held it in 5 quarters since. The position peaked at $17K in Q2 2025. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Hazlett, Burt & Watson held 215 shares of Bio-Techne worth $11K as of Q1 2026.
  • Hazlett, Burt & Watson left its Bio-Techne share count unchanged in Q1 2026.
  • Bio-Techne made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #686 holding.
  • Hazlett, Burt & Watson first reported a position in Bio-Techne in Q1 2025 and has held it in 5 quarters since.
  • Hazlett, Burt & Watson's Bio-Techne position peaked at $17K in Q2 2025.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.